Mirabegron
Mirabegron is an approved active ingredient.
Chemical compound
What it is used for
- Bladder disease
- Neurogenic bladder
- Urination disorder
- Overactive bladder
- Urinary incontinence
- Polyuria
- Urge incontinence
MYRBETRIQ is a beta-3 adrenergic agonist indicated for the treatment of: • Overactive bladder (OAB) in adult patients with symptoms of urge urinary incontinence, urgency, and urinary frequency, either alone or in combination with the muscarinic antagonist solifenacin succinate. • Neurogenic…
Overactive bladder in adults Betmiga prolonged-release tablets are indicated for symptomatic treatment of urgency, increased micturition frequency and/or urgency incontinence as may occur in adult patients with overactive bladder (OAB) syndrome.
How it works
- Beta-3 adrenergic receptor agonist
Common side effects
The following adverse reactions are discussed in more detail in other sections of the labeling. • Hypertension • Urinary Retention • Angioedema • Most commonly reported adverse reactions with MYRBETRIQ monotherapy in adult patients with OAB (> 2% and > placebo) were hypertension, nasopharyngitis, urinary tract…
Who should not take it
MYRBETRIQ/MYRBETRIQ Granules is contraindicated in patients with known hypersensitivity reactions to mirabegron or any inactive ingredients of the tablet or oral suspension.
Pregnancy and breastfeeding
There are no studies with the use of MYRBETRIQ/MYRBETRIQ Granules in pregnant women or adolescents to inform a drug-associated risk of major birth defects, miscarriages, or adverse maternal or fetal outcomes.
Interactions
Brand names
United States
Myrbetriq Granules
Canada
Apo-Mirabegron · Auro-Mirabegron · Sandoz Mirabegron
Approval status
- US Food and Drug Administration
- prescription · since 2012
- European Medicines Agency
- authorised · since 2012
- Health Canada
- prescription · marketed
- First approval anywhere
- 2012
Codes
- ATC
- G04BD12
- RxNorm CUI
- 1300786
- ChEMBL
- CHEMBL2095212
- PubChem CID
- 9865528
- UNII
- MVR3JL3B2V
- Wikidata
- Q3702534
Frequently asked questions
What is Mirabegron used for?
Mirabegron is used for: Bladder disease, Neurogenic bladder, Urination disorder, Overactive bladder, Urinary incontinence, Polyuria, and Urge incontinence.
What are the brand names of Mirabegron?
Brand names of Mirabegron include Myrbetriq Granules, Apo-Mirabegron, Auro-Mirabegron, and Sandoz Mirabegron.
Medicines in the same class
Sources and licences
- ChEMBL (CC BY-SA 3.0)
- Wikidata (CC0 1.0)
- openFDA / DailyMed (public domain)
- European Medicines Agency (reuse with acknowledgement)
- Health Canada Drug Product Database (Open Government Licence – Canada)